Product image of Glimepiride Sandoz (Glimepiride) supplied by GNH India

Glimepiride Sandoz

Active Ingredient:
Glimepiride
Origin:
EU

Glimepiride Sandoz (Glimepiride)

Glimepiride Sandoz is a generic oral tablet containing the active ingredient glimepiride, a sulfonylurea‑type antidiabetic agent. It is manufactured for the European market and prescribed for adults with type 2 diabetes mellitus to help control blood glucose. The product is available only by prescription, is taken by mouth, and follows EU quality standards for solid oral dosage forms. Each tablet provides a consistent dose and includes standard excipients.

Manufacturer / TM Owner

Sandoz N.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glimepiride Sandoz is indicated for the oral management of hyperglycemia in patients with type 2 diabetes mellitus when diet, exercise, and other non‑pharmacologic measures are insufficient.

  • As monotherapy in patients newly diagnosed with type 2 diabetes.
  • In combination with metformin when glycemic control is not achieved with metformin alone.
  • As part of a fixed‑dose combination regimen with other oral antidiabetic agents.
  • To improve fasting and post‑prandial blood glucose levels.
  • For use in adults whose renal function is stable and within recommended limits.

Side Effects

The safety profile of glimepiride includes a range of observed adverse events, most of which are dose‑related and reversible upon discontinuation.

Common

  • Mild hypoglycemia.
  • Weight gain.
  • Nausea or abdominal discomfort.
  • Headache.

Serious

  • Severe hypoglycemia with loss of consciousness.
  • Allergic skin reactions (rash, urticaria).
  • Liver enzyme elevations or hepatitis.

Precautions & Warnings

Before prescribing Glimepiride Sandoz, clinicians should evaluate patient-specific factors and monitor for conditions that may increase the risk of adverse outcomes.

  • Assess renal and hepatic function; dose adjustment may be required.
  • Review history of hypersensitivity to sulfonylureas.
  • Caution in elderly patients due to higher hypoglycemia risk.
  • Avoid use in patients with diabetic ketoacidosis.
  • Monitor for signs of hypoglycemia, especially when meals are missed.
  • Educate patients on recognizing and managing low blood glucose.

Avoid Interactions

Glimepiride can interact with several medicines, altering its glucose‑lowering effect or increasing the risk of side effects.

Avoid

  • Concurrent use with other sulfonylureas or meglitinides (additive hypoglycemia risk).
  • Strong CYP2C9 inhibitors such as fluconazole or amiodarone (increase glimepiride levels).
  • High‑dose salicylates (enhance hypoglycemic effect).

Use with caution

  • Beta‑blockers (mask hypoglycemia symptoms).
  • Thiazide diuretics (may impair glucose control).
  • ACE inhibitors or ARBs (monitor renal function).
  • Antidepressants like SSRIs (potential additive effect on blood sugar).

Frequently Asked Questions

Glimepiride Sandoz is a generic oral tablet that contains glimepiride, a sulfonylurea that stimulates insulin release from pancreatic beta cells by binding to the sulfonylurea receptor on the ATP‑sensitive potassium channel.

It is prescribed for adult patients with type 2 diabetes mellitus who need additional glucose control beyond diet, exercise, and other oral agents.

Glimepiride Sandoz is taken by mouth, usually once daily with breakfast or the first main meal, as directed by a healthcare professional.

Common side effects include mild hypoglycemia, weight gain, nausea or abdominal discomfort, and headache.

Hypoglycemia is most likely when meals are skipped, when the dose is higher than needed, or when the drug is combined with other glucose‑lowering agents.

Yes, it is often combined with metformin when metformin alone does not achieve target blood glucose levels.

Periodic monitoring of fasting blood glucose, HbA1c, renal function, and liver enzymes is recommended to assess efficacy and safety.

Patients should maintain a consistent carbohydrate intake and avoid excessive alcohol, which can increase the risk of hypoglycemia.

Reduced renal function may increase drug exposure; dose adjustment or increased monitoring may be necessary in patients with moderate to severe renal impairment.

If a dose is missed, the patient should take it as soon as they remember, unless it is close to the time of the next scheduled dose; they should not double the dose.

The safety of glimepiride in pregnancy has not been established; it should be used only if the potential benefit justifies the potential risk to the fetus.

Beta‑blockers may mask the typical symptoms of hypoglycemia, so patients on both medications should monitor blood glucose closely.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glimepiride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT